Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

The Role of STAT5 in HOXA9-Associated Leukemia

Peilin Ma, MD, PhD, Yuqing Sun, MS, Jingya Wang, PhD, Weihua Song, MD, PhD, Tao Xu, PhD, Reuben Kapur, PhD, Jay L. Hess, MD PhD

Blood (2016) 128 (22): 3919.

https://doi.org/10.1182/blood.V128.22.3919.3919

Published: 2016

Journal Articles

Ongoing Spontaneous DNA Damage and the Role of Aberrant Epigenome in Multiple Myeloma

Maria Gkotzamanidou, MD PhD, Masood Shammas, PhD, Vassilis L. Souliotis, Weihua Song, MD, Jagannath Pal, MBBS, PhD, Puru Nanjappa, MS, Naim Rashid, PhD, Kenneth C. Anderson, MD, Meletios A. Dimopoulos, MD, James Bradner, MD, Nikhil C. Munshi, MD

Blood (2014) 124 (21): 3398.

https://doi.org/10.1182/blood.V124.21.3398.3398

Published: 2014

Journal Articles

Bone Marrow Microenvironment Regulates Alternative Splicing Events in Myeloma Cells through Downregulation of RNA Binding Protein Fox2

Blood (2014) 124 (21): 4714.

https://doi.org/10.1182/blood.V124.21.4714.4714

Published: 2014

Journal Articles

Bone Marrow Microenvironment Affects The Pathogenesis Of Multiple Myeloma Through Downregulation Of Alternative Splicing Factor Fox2 In Myeloma Cells

Weihua Song, MD, Chaolin Zhang, PhD, Yiguo Hu, PhD, Maria Gkotzamanidou, MD, Parantu Shah, PhD, Weisong Shan, MD PhD, Guang Yang, PhD, Samir B. Amin, MBBS, Yu-Tzu Tai, PhD, Yi Li, PhD, Adam Sperling, MD, PhD, Naim Rashid, PhD, Florence Magrangeas, PhD, Stephane Minvielle, PhD, Hervé Avet-Loiseau, MD, PhD, Kenneth C. Anderson, MD, Cheng Li, PhD, Nikhil C. Munshi, MD

Blood (2013) 122 (21): 3085.

https://doi.org/10.1182/blood.V122.21.3085.3085

Published: 2013

Journal Articles

Induction of T Cell Immunity Using a Multipeptide Cocktail Containing XBP1, CD138 and CS1 Peptides in Smoldering Multiple Myeloma

Jooeun Bae, PhD, Rao H. Prabhala, Ph.D., Weihua Song, MD, Yu-Tzu Tai, PhD, Kenneth C. Anderson, Nikhil C Munshi, MD

Blood (2012) 120 (21): 5039.

https://doi.org/10.1182/blood.V120.21.5039.5039

Published: 2012

Journal Articles

Alternate Splicing Factor Fox2 Affects Growth and Survival of Multiple Myeloma Cells

Weihua Song, MD, Yiguo Hu, PhD, Guang Yang, PhD, Parantu K Shah, PhD, Weisong Shan, MD PhD, Yu-Tzu Tai, PhD, Yi Li, PhD, Stephane Minvielle, PhD, Hervé Avet-Loiseau, MD, PhD, Kenneth C. Anderson, MD, Cheng Li, PhD, Nikhil C. Munshi, MD

Blood (2011) 118 (21): 1810.

https://doi.org/10.1182/blood.V118.21.1810.1810

Published: 2011

Journal Articles

Novel Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders,

Jooeun Bae, Ph.D., Ruben Carrasco, MD, PhD, Ann-Hwee Lee, Ph.D., Rao Prabhala, Ph.D., Yu-Tzu Tai, PhD, Weihua Song, MD, Kenneth C Anderson, MD, Nikhil C. Munshi, MD

Blood (2011) 118 (21): 3990.

https://doi.org/10.1182/blood.V118.21.3990.3990

Published: 2011

Journal Articles

Perifosine Affects Phenotype and Function of Human Myeloid Dendritic Cells

Weihua Song, MD, Teru Hideshima, Yu-Tzu Tai, PhD, Rao H Prabhala, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2010) 116 (21): 3911.

https://doi.org/10.1182/blood.V116.21.3911.3911

Published: 2010

Journal Articles

Lenalidomide Enhances Multiple Myeloma Cytotoxicity Induced by a Novel Fc Domain-Engineered Anti-HM1.24 Monoclonal Antibody with Augmented NK Cell Degranulation

Sun-Young Kong, MD, PhD, Sabikun Nahar, Xian-Feng Li, Weihua Song, MD, Yiguo Hu, Umesh Muchhal, John Desjarlais, Paul Richardson, M.D., Ph.D., Nikhil C. Munshi, MD, Kenneth C. Anderson, Yu-Tzu Tai, PhD

Blood (2010) 116 (21): 4064.

https://doi.org/10.1182/blood.V116.21.4064.4064

Published: 2010

Journal Articles

Human Monoclonal Antibody Targeting IL-17A (AIN457) Down-Regulates MM Cell-Growth and Survival and Inhibits Osteoclast Development In Vitro and In Vivo: A Potential Novel Therapeutic Application In Myeloma

Rao H Prabhala, PH.D., Mariateresa Fulciniti, PhD, Dheeraj Pelluru, PhD, Puru Nanjappa, MS, Christine Pai, BS, Saem Lee, B.A., Nithya Prabhala, Weihua Song, MD, Constantine S. Mitsiades, MD, PhD, Konstantinos Lefkimmiatis, PhD, Yu-Tzu Tai, PhD, Irene Ghobrial, MD, Paul Richardson, MD, John Daley, Kenneth C. Anderson, MD, Seth Ettenberg, Franco Di Padova, Nikhil C. Munshi, MD

Blood (2010) 116 (21): 456.

https://doi.org/10.1182/blood.V116.21.456.456

Published: 2010

Journal Articles

Daratumumab Directly Induces Human Multiple Myeloma Cell Death and Acts Synergistically with Conventional and Novel Anti-Myeloma Drugs

Sun-Young Kong, MD, PhD, Xian-Feng Li, Sabikun Nahar, Weihua Song, MD, Michel de Weers, Paul W.H.I. Parren, Paul Richardson, M.D., Ph.D., Nikhil C. Munshi, MD, Kenneth C. Anderson, Yu-Tzu Tai, PhD

Blood (2010) 116 (21): 3013.

https://doi.org/10.1182/blood.V116.21.3013.3013

Published: 2010

Journal Articles

Elevated IL-17 produced by Th17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma

Rao H. Prabhala, Dheeraj Pelluru, Mariateresa Fulciniti, Harsha K. Prabhala, Puru Nanjappa, Weihua Song, Christine Pai, Samir Amin, Yu-Tzu Tai, Paul G. Richardson, Irene M. Ghobrial, Steven P. Treon, John F. Daley, Kenneth C. Anderson, Jeffery L. Kutok, Nikhil C. Munshi

Blood (2010) 115 (26): 5385–5392.

https://doi.org/10.1182/blood-2009-10-246660

Published: 2010

Journal Articles

HDAC Inhibition by LBH589 Affects Phenotype and Function of Human Dendritic Cells.

Weihua Song, MD, Yu-Tzu Tai, Ph.D., Ze Tian, Ph.D, Teru Hideshima, M.D., Ph.D., Dharminder Chauhan, Ph.D, Puru Nanjappa, MS, Mark A. Exley, Ph.D, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2009) 114 (22): 1646.

https://doi.org/10.1182/blood.V114.22.1646.1646

Published: 2009

Journal Articles

Phenotypic and Functional Effects of Novel HDAC Inhibitor LBH589 On Human Lymphocyte Populations.

Weihua Song, MD, Yu-Tzu Tai, PhD, Teru Hideshima, MD, PhD, Kenneth C. Anderson, Nikhil C. Munshi

Blood (2009) 114 (22): 3681.

https://doi.org/10.1182/blood.V114.22.3681.3681

Published: 2009

Journal Articles

Targeting MEK1/2 Signaling Cascade by AS703026, a Novel Selective MEK1/2 Inhibitor, Induces Pleiotropic Anti-Myeloma Activity in Vitro and In Vivo.

Yu-Tzu Tai, Ph.D., Kihyun Kim, M.D., Xian-Feng Li, M.S., Mariateresa Fulciniti, Ph.D., Weihua Song, M.D., Sabikun Nahar, B.S., Peter Burger, B.S., Mathew J. Rumizen, Klaus Podar, M.D., Ph.D., Dharminder Chauhan, Ph.D, Teru Hideshima, M.D., Ph.D., Robert L Schlossman, M.D., Ph.D., Nikhil C. Munshi, Paul Richardson, M.D., Ph.D., Ann Clark, Ph.D., Janet Ogden, Ph.D., Goutopoulos Andreas, Ph.D., Luca Rastelli, Ph.D., Kenneth C. Anderson, MD

Blood (2009) 114 (22): 3848.

https://doi.org/10.1182/blood.V114.22.3848.3848

Published: 2009

Journal Articles

Daratumumab, a Novel Potent Human Anti-CD38 Monoclonal Antibody, Induces Significant Killing of Human Multiple Myeloma Cells: Therapeutic Implication.

Yu-Tzu Tai, Ph.D., Michel de Weers, Ph.D., Xian-Feng Li, MS, Weihua Song, MD, Sabikun Nahar, B.S., Joost M Bakker, Tom Vink, Daniëlle Jacobs, Lukas Oomen, Wim K Bleeker, Nikhil C. Munshi, MD, Jan G. J. van de Winkel, PhD, Paul W. H. I. Parren, PhD, Paul Richardson, M.D., Ph.D., Kenneth C. Anderson, MD

Blood (2009) 114 (22): 608.

https://doi.org/10.1182/blood.V114.22.608.608

Published: 2009

Journal Articles

XmAb®5592 Fc-Engineered Humanized Anti-HM1.24 Monoclonal Antibody Has Potent in Vitro and In Vivo Efficacy against Multiple Myeloma.

Yu-Tzu Tai, Ph.D., Umesh Muchhal, Ph.D., Xian-Feng Li, MS, Sabikun Nahar, B.S., Weihua Song, MD, Holly Horton, Ph.D, Hanh Nguyen, Sher Karki, John Desjarlais, Nikhil C. Munshi, MD, Paul Richardson, M.D., Ph.D., Kenneth C. Anderson, MD

Blood (2009) 114 (22): 609.

https://doi.org/10.1182/blood.V114.22.609.609

Published: 2009

Journal Articles

CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf–mediated interactions with bone marrow stromal cells

Yu-Tzu Tai, Ender Soydan, Weihua Song, Mariateresa Fulciniti, Kihyun Kim, Fangxin Hong, Xian-Feng Li, Peter Burger, Matthew J. Rumizen, Sabikun Nahar, Klaus Podar, Teru Hideshima, Nikhil C. Munshi, Giovanni Tonon, Ruben D. Carrasco, Daniel E. H. Afar, Kenneth C. Anderson

Blood (2009) 113 (18): 4309–4318.

https://doi.org/10.1182/blood-2008-10-183772

Published: 2009

Journal Articles

CS1 Promotes Multiple Myeloma Cell Adhesion, Clonogenic Growth, and Tumorigenicity Via C-Maf-Mediated Interactions with Bone Marrow Stromal Cells (BMSCs)

Yu-Tzu Tai, PhD, Ender Soydan, Mariateresa Fulciniti, Weihua Song, Xian-Feng Li, Peter Burger, Fangxin Hong, Giovanni Tonon, Kihyun Kim, Mathew J. Rumizen, Sabikun Nahar, Klaus Podar, Dharminder Chauhan, Teru Hideshima, Daniel R. Carrasco, Nikhil C Munshi, Daniel Afar, PhD, Kenneth C. Anderson

Blood (2008) 112 (11): 840.

https://doi.org/10.1182/blood.V112.11.840.840

Published: 2008

Journal Articles

Phenotypic and Functional Effects of Novel Akt Inhibitor Perifosine on Immune System.

Weihua Song, MD, Teru Hideshima, MD, PhD, Yu-Tzu Tai, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2008) 112 (11): 1555.

https://doi.org/10.1182/blood.V112.11.1555.1555

Published: 2008

NARROW

The Role of STAT5 in HOXA9-Associated Leukemia

Ongoing Spontaneous DNA Damage and the Role of Aberrant Epigenome in Multiple Myeloma

Bone Marrow Microenvironment Regulates Alternative Splicing Events in Myeloma Cells through Downregulation of RNA Binding Protein Fox2

Bone Marrow Microenvironment Affects The Pathogenesis Of Multiple Myeloma Through Downregulation Of Alternative Splicing Factor Fox2 In Myeloma Cells

Induction of T Cell Immunity Using a Multipeptide Cocktail Containing XBP1, CD138 and CS1 Peptides in Smoldering Multiple Myeloma

Alternate Splicing Factor Fox2 Affects Growth and Survival of Multiple Myeloma Cells

Novel Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders,

Perifosine Affects Phenotype and Function of Human Myeloid Dendritic Cells

Lenalidomide Enhances Multiple Myeloma Cytotoxicity Induced by a Novel Fc Domain-Engineered Anti-HM1.24 Monoclonal Antibody with Augmented NK Cell Degranulation

Human Monoclonal Antibody Targeting IL-17A (AIN457) Down-Regulates MM Cell-Growth and Survival and Inhibits Osteoclast Development In Vitro and In Vivo: A Potential Novel Therapeutic Application In Myeloma

Daratumumab Directly Induces Human Multiple Myeloma Cell Death and Acts Synergistically with Conventional and Novel Anti-Myeloma Drugs

Elevated IL-17 produced by Th17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma

HDAC Inhibition by LBH589 Affects Phenotype and Function of Human Dendritic Cells.

Phenotypic and Functional Effects of Novel HDAC Inhibitor LBH589 On Human Lymphocyte Populations.

Targeting MEK1/2 Signaling Cascade by AS703026, a Novel Selective MEK1/2 Inhibitor, Induces Pleiotropic Anti-Myeloma Activity in Vitro and In Vivo.

Daratumumab, a Novel Potent Human Anti-CD38 Monoclonal Antibody, Induces Significant Killing of Human Multiple Myeloma Cells: Therapeutic Implication.

XmAb®5592 Fc-Engineered Humanized Anti-HM1.24 Monoclonal Antibody Has Potent in Vitro and In Vivo Efficacy against Multiple Myeloma.

CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf–mediated interactions with bone marrow stromal cells

CS1 Promotes Multiple Myeloma Cell Adhesion, Clonogenic Growth, and Tumorigenicity Via C-Maf-Mediated Interactions with Bone Marrow Stromal Cells (BMSCs)

Phenotypic and Functional Effects of Novel Akt Inhibitor Perifosine on Immune System.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only